Hepatobiliary and Pancreatic: Nivolumab‐related cholangiopathy

Saved in:
Bibliographic Details
Published in:Journal of gastroenterology and hepatology 2018-10, Vol.33 (10), p.1695-1695
Main Authors: Hamoir, C, Vos, M, Clinckart, F, Nicaise, G, Komuta, M, Lanthier, N
Format: Article
Language:English
Subjects:
Aged
Antineoplastic Agents, Immunological - adverse effects
Bile Ducts, Intrahepatic - diagnostic imaging
Bile Ducts, Intrahepatic - pathology
Carcinoma, Non-Small-Cell Lung - therapy
Cholangiopancreatography, Magnetic Resonance
Cholangitis - chemically induced
Cholangitis - diagnostic imaging
Cholangitis - pathology
Humans
Immunotherapy
Immunotherapy - adverse effects
Lung Neoplasms - therapy
Male
Monoclonal antibodies
Nivolumab - adverse effects
Pancreas
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0815-9319
1440-1746
DOI:10.1111/jgh.14136